期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 36, 期 2, 页码 160-+出版社
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2017.75.3467
关键词
-
类别
资金
- PharmaMar
- GlaxoSmithKline
- Novartis
- MSD
- AstraZeneca
- NATIONAL CANCER INSTITUTE [ZIASC010354] Funding Source: NIH RePORTER
Undifferentiated pleomorphic sarcomas, myxofibrosarcomas, and malignant peripheral nerve sheath tumors are characterized by complex genomic characteristics and aggressive clinical behavior. Recent advances in the understanding of the pathogenesis of these tumors may allow for the development of more-effective innovative therapeutic strategies, including immunotherapies. This review describes the current knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of these tumors and highlights ongoing and future research. (c) 2017 by American Society of Clinical Oncology
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据